3Fishman CA,Father M,Patel BS,Visual acuity loss in patient with Stargardt's macular dystrophy.Ophatalmol,1987,94:809-914. 被引量:1
4Noble KG,Carr RE,Stargardt's disease and fundus flavimaculatus.Arch Ophthalmol,1979,97:1281-1285. 被引量:1
5Bonnin P,Le signe du silence choroidien dans les degenerescence tapeto-retinicannies centrales examinees sous fluoresceine.Bull Soe Ophthalmol Fr,1971,71:348-351. 被引量:1
6Delori FC,Staurenghi G,Arend O,et al.vivo measurement of lipofusin in Stargardt's disease fundus flavimaculatus.Invest Ophthaimol Vis Sei,1995,36:2327-2331. 被引量:1
7Wroblewski JJ,Gitter KA,Cohen G,Indocyanine green angiography in Stargardt's flavimaculatus.Am J Ophthalmol,1995,120:208-218. 被引量:1
8Hartnett ME,Elsner AE,Characteristics of exudative age-related macular degeneration determined in vivo with confocal and indirect infrared imaging.Ophthalmol,1996,103:58-71. 被引量:1
9Macular Phtoocoagulation Study Group.Neovascular subfoveal lesions in age-related macular degeneration:Guidelines for exudation and treatment in the macular photocoagulation study.Arch Ophthalmol,1991,109:1242-1258. 被引量:1